OOI
14 FDA 510(k) clearances · Product code
88 daysmedian time to decision
249 days90th percentile
14clearances measured
FDA profile
- Official device name
- Real Time Nucleic Acid Amplification System
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 862.2570
- Medical specialty
- Clinical Chemistry
- FDA definition
- The system is a clinical multiplex instrument intended to measure and sort multiple signals generated my multiple probes, intercalating dyes, or other ligands in an assay from a clinical sample. Signals may be generated by fluorescence or other phenomena and may be measured using filters on a photodiode or other detector. It may integrate sample and/or reagent handling, amplification, dedicated instrument control, data acquisition software, raw data storage mechanisms and other essential hardware components along with the signal reader unit. The system is used with specific assays to comprise an assay test system.
- Adverse events (MAUDE)
- 2021: 324 · 2022: 874 · 2023: 220 · 2024: 328 · 2025: 533 · 2026: 313
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
Track OOI automatically
Every clearance here is in the API, with alerts when new ones post.